253 related articles for article (PubMed ID: 35633464)
1. Cytomegalovirus infection and rehospitalization rates after allogeneic hematopoietic stem cell and solid organ transplantation: a retrospective cohort study using German claims data.
Teschner D; Knop J; Piehl C; Junker S; Witzke O
Infection; 2022 Dec; 50(6):1543-1555. PubMed ID: 35633464
[TBL] [Abstract][Full Text] [Related]
2. The Incidence and Effect of Cytomegalovirus Disease on Mortality in Transplant Recipients and General Population: Real-world Nationwide Cohort Data.
Han SH; Yoo SG; Do Han K; La Y; Kwon DE; Lee KH
Int J Med Sci; 2021; 18(14):3333-3341. PubMed ID: 34400903
[No Abstract] [Full Text] [Related]
3. Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies.
Girmenia C; Lazzarotto T; Bonifazi F; Patriarca F; Irrera G; Ciceri F; Aversa F; Citterio F; Cillo U; Cozzi E; Gringeri E; Baldanti F; Cavallo R; Clerici P; Barosi G; Grossi P
Clin Transplant; 2019 Oct; 33(10):e13666. PubMed ID: 31310687
[TBL] [Abstract][Full Text] [Related]
4. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality.
Liu J; Kong J; Chang YJ; Chen H; Chen YH; Han W; Wang Y; Yan CH; Wang JZ; Wang FR; Chen Y; Zhang XH; Xu LP; Liu KY; Huang XJ
Clin Microbiol Infect; 2015 Dec; 21(12):1121.e9-15. PubMed ID: 26093077
[TBL] [Abstract][Full Text] [Related]
5. Impact of cytomegalovirus complications on resource utilization and costs following hematopoietic stem cell transplant.
Schelfhout J; Bonafede M; Cappell K; Cole AL; Manjelievskaia J; Raval AD
Curr Med Res Opin; 2020 Jan; 36(1):33-41. PubMed ID: 31490093
[No Abstract] [Full Text] [Related]
6. Cytomegalovirus infection and associated hospitalization and costs among individuals undergoing allogeneic hematopoietic stem cell transplant.
Schelfhout J; Brown H; House JA; Raval AD
Curr Med Res Opin; 2020 Jan; 36(1):43-50. PubMed ID: 31490097
[No Abstract] [Full Text] [Related]
7. The clinical and economic burden of cytomegalovirus management post allogeneic hematopoietic stem cell transplantation in Japan - a retrospective database study.
Ueno R; Nishimura S; Fujimoto G; Piao Y; Takenaka K
Curr Med Res Opin; 2019 Dec; 35(12):2089-2096. PubMed ID: 31353971
[No Abstract] [Full Text] [Related]
8. Evaluation of treatment patterns, healthcare resource utilization, and costs among patients receiving treatment for cytomegalovirus following allogeneic hematopoietic cell or solid organ transplantation.
Cheng WY; Avery RK; Thompson-Leduc P; Cheung HC; Bo T; Duh MS; Hirji I
J Med Econ; 2022; 25(1):367-380. PubMed ID: 35240904
[TBL] [Abstract][Full Text] [Related]
9. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.
Webb BJ; Harrington R; Schwartz J; Kammerer J; Spalding J; Lee E; Dodds B; Kaufusi S; Goodman BE; Firth SD; Martin G; Sorensen J; Hoda D
Transpl Infect Dis; 2018 Oct; 20(5):e12961. PubMed ID: 29975816
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic yield of the cytomegalovirus (CMV) antigenemia assay and clinical features in solid organ transplant recipients and hematopoietic stem cell transplant recipients with CMV pneumonia.
Moon SM; Sung H; Kim MN; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
Transpl Infect Dis; 2012 Apr; 14(2):192-7. PubMed ID: 22260384
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study.
Serio B; Giudice V; Guariglia R; Fontana R; Pezzullo L; Martorelli MC; Ferrara I; Mettivier L; D'Addona M; Vaccaro E; Langella M; Selleri C
Infez Med; 2021 Mar; 29(1):102-113. PubMed ID: 33664179
[TBL] [Abstract][Full Text] [Related]
12. An investigation of the utility of plasma Cytomegalovirus (CMV) microRNA detection to predict CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
Talaya A; Giménez E; Pascual MJ; Gago B; Piñana JL; Hernández-Boluda JC; Vázquez L; García M; Serrano D; Hernández M; Albert E; Solano C; Navarro D
Med Microbiol Immunol; 2020 Feb; 209(1):15-21. PubMed ID: 31478067
[TBL] [Abstract][Full Text] [Related]
13. Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.
Romero S; Montoro J; Guinot M; Almenar L; Andreu R; Balaguer A; Beneyto I; Espí J; Gómez-Codina J; Iacoboni G; Jarque I; López-Andújar R; Mayordomo-Aranda E; Montalar J; Pastor A; Pastor M; Piñana JL; Rojas-Ferrer N; Sánchez-Lázaro I; Sandoval J; Sanz G; Sanz MÁ; Solé A; Sanz J
Leuk Lymphoma; 2019 Jan; 60(1):142-150. PubMed ID: 29966464
[TBL] [Abstract][Full Text] [Related]
14. Features of cytomegalovirus infection and evaluation of cytomegalovirus-specific T cells therapy in children's patients following allogeneic hematopoietic stem cell transplantation: A retrospective single-center study.
Ruan Y; Luo T; Liu Q; Liu X; Chen L; Wen J; Xiao Y; Xie D; He Y; Wu X; Feng X
Front Cell Infect Microbiol; 2022; 12():1027341. PubMed ID: 36339340
[TBL] [Abstract][Full Text] [Related]
15. Cecum ulcer is a reliable endoscopic finding in cytomegalovirus colitis concomitant with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Matsuda K; Ono S; Ishikawa M; Miyamoto S; Abiko S; Tsuda M; Yamamoto K; Kudo T; Shimizu Y; Hayase E; Hashimoto D; Teshima T; Matsuno Y; Sakamoto N
Ann Hematol; 2018 May; 97(5):877-883. PubMed ID: 29340759
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of inflammatory biomarkers in plasma predict the occurrence and features of cytomegalovirus DNAemia episodes in allogeneic hematopoietic stem cell transplant recipients.
Talaya A; Giménez E; Vinuesa V; Pérez A; Amat P; Piñana JL; Albert E; Hernández-Boluda JC; Solano C; Navarro D
Med Microbiol Immunol; 2019 Aug; 208(3-4):405-414. PubMed ID: 30911925
[TBL] [Abstract][Full Text] [Related]
18. Ten-year epidemiology and risk factors of cytomegalovirus infection in hematopoietic stem cell transplantation patients in Taiwan.
Huang YC; Hsiao FY; Guan ST; Yao M; Liu CJ; Chen TT; Lin TL; Liu YC; Chen TY; Hong YC; Ma MC; Tan TD; Wang CC; Wu YY; Liao PW; Wu YF; Chen YY; Yu YB; Hsieh YY; Lee MY; Liu JH; Lin SW; Ko BS
J Microbiol Immunol Infect; 2024 Jun; 57(3):365-374. PubMed ID: 38503632
[TBL] [Abstract][Full Text] [Related]
19. Optimizing the treatment of cytomegalovirus infection in allo-HSCT recipients.
Sun YQ; Ma R; Huang XJ
Expert Rev Clin Immunol; 2023 Feb; 19(2):227-235. PubMed ID: 36541485
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of human herpesvirus-6 in allogeneic hematopoietic stem cell transplant recipients in correlation with cytomegalovirus infection].
Wang LR; Dong LJ; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1204-9. PubMed ID: 17204195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
